Home › Funds › Blue Owl Capital Holdings LP › ADCT
Blue Owl Capital Holdings LP position in ADCT
ADC THERAPEUTICS SA · Health Care
Blue Owl Capital Holdings LP reported holding 733,568 shares of ADCT (ADC THERAPEUTICS SA) in its Q3 2026 13F filing — a position valued at US$895K, representing 0.17% of its reported portfolio and ranking #34 among its reported holdings. Blue Owl Capital Holdings LP has disclosed ADCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Blue Owl Capital Holdings LP's ADCT position evolved
Blue Owl Capital Holdings LP first disclosed a stake in ADCT in Q3 2023 at 733,568 shares (US$654K). The position peaked in Q1 2024 at 733,568 shares, worth US$3.3M. Across 13 filings, Blue Owl Capital Holdings LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 733,568 shares valued at US$895K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 733.57K | $654.49K | New |
| Q4 2023 | 733.57K | $1.22M | Hold |
| Q1 2024 | 733.57K | $3.29M | Hold |
| Q2 2024 | 733.57K | $2.32M | Hold |
| Q3 2024 | 733.57K | $2.31M | Hold |
| Q4 2024 | 733.57K | $1.46M | Hold |
| Q1 2025 | 733.57K | $1.03M | Hold |
| Q2 2025 | 733.57K | $1.97M | Hold |
| Q3 2025 | 733.57K | $2.93M | Hold |
| Q4 2025 | 733.57K | $2.93M | Hold |
| Q1 2026 | 733.57K | $2.59M | Hold |
| Q2 2026 | 733.57K | $784.92K | Hold |
| Q3 2026 | 733.57K | $894.95K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ADCT and 13F data
ADCT (ADC THERAPEUTICS SA) is a Health Care company. 28 other funds we track also report a position in ADCT — the largest reported positions include Redmile Group, LLC (US$12.3M), TCG Crossover Management, LLC (US$12.2M), Prosight Management, LP (US$8.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADCT
- Redmile Group, LLC 11.53M sh · $12.33M · Q2 2026
- TCG Crossover Management, LLC 11.39M sh · $12.19M · Q2 2026
- Prosight Management, LP 7.82M sh · $8.37M · Q2 2026
- AIGH Capital Management LLC 4.32M sh · $5.28M · Q3 2026
More on Blue Owl Capital Holdings LP
FAQ
How long has Blue Owl Capital Holdings LP held ADCT?
Blue Owl Capital Holdings LP has disclosed ADCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Blue Owl Capital Holdings LP's current position in ADCT?
As of Q3 2026, Blue Owl Capital Holdings LP holds 733.57K shares of ADCT (ADC THERAPEUTICS SA), valued at $894.95K, representing 0.17% of its reported portfolio and ranking #34.
Has Blue Owl Capital Holdings LP been buying or selling ADCT?
In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP held unchanged its position in ADCT. The position peaked in Q1 2024 at 733.57K shares.
Which other funds hold ADCT?
Other major institutional holders of ADCT include Redmile Group, LLC, TCG Crossover Management, LLC, Prosight Management, LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.